Top 5 Most Read RNS's on Vox Markets for Tuesday 13th December 2022
Episode 1076, Dec 13, 2022, 07:56 AM
Top 5 Most Read RNS's on Vox Markets for Tuesday 13th December 2022
5. Futura Medical PLC - Futura Medical announce milestone year for MED3000
The first marketing authorisation for MED3000 has now been granted in three Middle Eastern countries including the UAE.
In the US based on the FDA's published target review period guidelines, granting of marketing authorisation remains on track to be achieved by the end of Q1 2023, in line with previously announced timelines.
4. Caracal Gold #GCAT - Sample Assay Results Confirm Mineralisation
Caracal Gold announces sample assay results from its Diamond Drilling programme on the Vim Rutha prospect, intercepted, on several occasions one or more mineralised structures of significant thickness located a few hundred metres south of Kilimapesa Hill.
3. Predator O&G Hldgs #PRD - Operations Update
Predator Oil & Gas Holdings provideS an update on progress towards the commencement of drilling of the high impact/high reward MOU-2 well in Guercif onshore northern Morocco.
Initial mobilisation of drilling rig and equipment to MOU-2 & Drilling operations expected to take 12 - 15 days.
2. Shield Therapeutics #STX - Placing & Subscription to raise approx. US$18m
Shield Therapeutics announces a proposed equity fundraising by way of a subscription and placing to raise approximately £14.7m at a price per share of 6 pence. The Company also announces it will be making an Open Offer to Qualifying Shareholders to raise up to a further £3.9m.
Collaborative Sales Agreement signed with Viatris
Shield Therapeutics also announced today that it has entered into an exclusive, multi-year agreement with Viatris Inc. (NASDAQ: VTRS), a global healthcare company, to co-commercialize Accrufer®.
The collaboration will result in a 100 person sales team who will promote Accrufer® to over 12,000 Health Care Professionals who write the majority of oral iron prescriptions.
1. Argo Blockchain #ARB - Restoration of Trading on the LSE
The Company is at risk of having insufficient cash to support ongoing business operations within the next month. The Company is in advanced negotiations with a third party to sell certain assets and engage in an equipment financing transaction that the Company believes will strengthen its balance sheet and improve its liquidity.
5. Futura Medical PLC - Futura Medical announce milestone year for MED3000
The first marketing authorisation for MED3000 has now been granted in three Middle Eastern countries including the UAE.
In the US based on the FDA's published target review period guidelines, granting of marketing authorisation remains on track to be achieved by the end of Q1 2023, in line with previously announced timelines.
4. Caracal Gold #GCAT - Sample Assay Results Confirm Mineralisation
Caracal Gold announces sample assay results from its Diamond Drilling programme on the Vim Rutha prospect, intercepted, on several occasions one or more mineralised structures of significant thickness located a few hundred metres south of Kilimapesa Hill.
3. Predator O&G Hldgs #PRD - Operations Update
Predator Oil & Gas Holdings provideS an update on progress towards the commencement of drilling of the high impact/high reward MOU-2 well in Guercif onshore northern Morocco.
Initial mobilisation of drilling rig and equipment to MOU-2 & Drilling operations expected to take 12 - 15 days.
2. Shield Therapeutics #STX - Placing & Subscription to raise approx. US$18m
Shield Therapeutics announces a proposed equity fundraising by way of a subscription and placing to raise approximately £14.7m at a price per share of 6 pence. The Company also announces it will be making an Open Offer to Qualifying Shareholders to raise up to a further £3.9m.
Collaborative Sales Agreement signed with Viatris
Shield Therapeutics also announced today that it has entered into an exclusive, multi-year agreement with Viatris Inc. (NASDAQ: VTRS), a global healthcare company, to co-commercialize Accrufer®.
The collaboration will result in a 100 person sales team who will promote Accrufer® to over 12,000 Health Care Professionals who write the majority of oral iron prescriptions.
1. Argo Blockchain #ARB - Restoration of Trading on the LSE
The Company is at risk of having insufficient cash to support ongoing business operations within the next month. The Company is in advanced negotiations with a third party to sell certain assets and engage in an equipment financing transaction that the Company believes will strengthen its balance sheet and improve its liquidity.